Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 1
2019 2
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy.
Heidari M, Noorizadeh F, Wu K, Inomata T, Mashaghi A. Heidari M, et al. J Clin Med. 2019 Sep 11;8(9):1439. doi: 10.3390/jcm8091439. J Clin Med. 2019. PMID: 31514344 Free PMC article. Review.
Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches
Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; ho
Defining the needs and preferences of patients with dry eye disease.
Asbell P, Messmer E, Chan C, Johnson G, Sloesen B, Cook N. Asbell P, et al. BMJ Open Ophthalmol. 2019 Dec 5;4(1):e000315. doi: 10.1136/bmjophth-2019-000315. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31909189 Free PMC article.
OBJECTIVE: Dry eye disease is a multifactorial chronic disease, leading to ocular discomfort and visual disturbance with a substantial impact on quality of life. ...We have developed a step-by-step methodology based on the self-explicated conjoint a
OBJECTIVE: Dry eye disease is a multifactorial chronic disease, leading to ocular discomfort and visual disturba …
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.
Cote S, Zhang AC, Ahmadzai V, Maleken A, Li C, Oppedisano J, Nair K, Busija L, Downie LE. Cote S, et al. Cochrane Database Syst Rev. 2020 Mar 18;3(3):CD013559. doi: 10.1002/14651858.CD013559. Cochrane Database Syst Rev. 2020. PMID: 32182637
BACKGROUND: Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease, which is the more prevalent form of dry eye disease. ...OBJECTIVES: To evaluate the effectiveness and safety of intense pulsed light (IPL) fo …
BACKGROUND: Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease, which is the more prev …
Nanoscale poly(acrylic acid)-based hydrogels prepared via a green single-step approach for application as low-viscosity biomimetic fluid tears.
Swilem AE, Elshazly AHM, Hamed AA, Hegazy EA, Abd El-Rehim HA. Swilem AE, et al. Mater Sci Eng C Mater Biol Appl. 2020 May;110:110726. doi: 10.1016/j.msec.2020.110726. Epub 2020 Feb 4. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32204037
Furthermore, neutralized nanogels were topically applied in a dry eye model and compared with a PAAc-based commercial tear substitute, namely Vidisic Gel. The results of Schirmer's test and tear break-up time demonstrated that nanogels prepared from AAc-rich …
Furthermore, neutralized nanogels were topically applied in a dry eye model and compared with a PAAc-based commercial tear sub …
Qualitative assessment of attributes and ease of use of the ELLIPTA dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
Svedsater H, Dale P, Garrill K, Walker R, Woepse MW. Svedsater H, et al. BMC Pulm Med. 2013 Dec 7;13:72. doi: 10.1186/1471-2466-13-72. BMC Pulm Med. 2013. PMID: 24314123 Free PMC article. Clinical Trial.
Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and adherence may affect treatment outcomes. In this study, patient experience of using a dry powder inhaler (DPI), the ELLIPTA DPI, in clinical trials of a n …
Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and adherence may affect …
Interferon alpha and its contribution to autoimmunity.
Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME. Selmi C, et al. Curr Opin Investig Drugs. 2006 May;7(5):451-6. Curr Opin Investig Drugs. 2006. PMID: 16729722 Review.
It is now well accepted that interferon (IFN)alpha plays a critical role in the pathogenesis and perpetuation of specific autoimmune diseases, including systemic lupus erythematosus (SLE), autoimmune thyroid disease and type 1 diabetes. IFNalpha-based treatments are …
It is now well accepted that interferon (IFN)alpha plays a critical role in the pathogenesis and perpetuation of specific autoimmune dise